title: Statin use and risk of nonmelanoma skin cancer: a nationwide study in Denmark.
abstract: BACKGROUND
  Evidence is conflicting regarding statin use and risk of basal cell (BCC) and squamous cell skin cancer (SCC).
  
  
  METHODS
  Using Danish nationwide registries, we identified all patients with incident BCC/SCC during 2005-2009 and matched them to population controls. We computed odds ratios (ORs) for BCC and SCC associated with statin use.
  
  
  RESULTS
  We identified 38,484 cases of BCC and 3724 cases of SCC. Statin ever use was associated with ORs of 1.09 (CI: 1.06-1.13) for BCC and 1.01 (CI: 0.91-1.11) for SCC.
  
  
  CONCLUSIONS
  Statin use was not associated with risk of SCC. Residual confounding plausibly explains the marginally increased risk of BCC.
authors.affiliation: Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, J.B. Winsløws Vej 19, 2.sal, 5000 Odense C, Denmark.
authors.forename: S
authors.initials: S
authors.lastname: Arnspang
authors.affiliation: 1] Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, J.B. Winsløws Vej 19, 2.sal, 5000 Odense C, Denmark [2] Department of Clinical Chemistry & Pharmacology, Odense University Hospital, J.B. Winsløws Vej 19, 2.sal, 5000 Odense C, Denmark.
authors.forename: A
authors.initials: A
authors.lastname: Pottegård
authors.affiliation: 1] Danish Cancer Society Research Centre, Strandboulevarden 49, 2100, Copenhagen Ø, Denmark [2] Faculty of Health, Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark [3] Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
authors.forename: S
authors.initials: S
authors.lastname: Friis
authors.affiliation: Department of Clinical Pathology, Odense University Hospital, J.B. Winsløws Vej 15, 5000 Odense C, Denmark.
authors.forename: O
authors.initials: O
authors.lastname: Clemmensen
authors.affiliation: Department of Dermatology and Allergy Centre, Odense University Hospital, Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Sdr. Boulevard 29, 5000 Odense C, Denmark.
authors.forename: K E
authors.initials: KE
authors.lastname: Andersen
authors.affiliation: 1] Clinical Pharmacology, Institute of Public Health, University of Southern Denmark, J.B. Winsløws Vej 19, 2.sal, 5000 Odense C, Denmark [2] Department of Clinical Chemistry & Pharmacology, Odense University Hospital, J.B. Winsløws Vej 19, 2.sal, 5000 Odense C, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Hallas
authors.affiliation: Department of Neurology, Odense University Hospital, Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Sdr. Boulevard 29, 5000 Odense C, Denmark.
authors.forename: D
authors.initials: D
authors.lastname: Gaist
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D003718:Denmark / Q000453:epidemiology; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D012306:Risk; D012878:Skin Neoplasms / Q000453:epidemiology*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors